UnitedHealthcare Trades 1.3 Million MA Members for Margin Gains in the Largest Medicare Advantage Repricing in History

UnitedHealthcare entered 2026 with roughly 8.4 million Medicare Advantage members and a Medical Care Ratio that had drifted toward 90% through mid-2025. It repriced, cut supplemental benefits, exited 190 counties across 16 states, and now projects losing 1.3 to 1.4 million MA members. Q1 2026 came in at an 83.9% MCR, down 90 basis points year over year. The membership number is the largest deliberate reduction in the programme's history.

Key Takeaways

• 965,000 MA seniors and 220,000 Medicaid managed care members left in Q1 2026, with a further 180,000 affected by county withdrawals and a projected 2.3 to 2.8 million decline across all lines for the year.
• 1.3 million against 35 million national MA enrollment is roughly 3.7% of the entire programme moving out of one carrier in a single plan year.
• 89.4% MBR at Humana, up 240 basis points, after absorbing about 1.2 million new MA members, which sits 550 basis points above UnitedHealthcare's 83.9%.
• $500 million of favourable prior-year reserve development sits inside the Q1 MCR improvement and does not repeat at that magnitude.

What the Membership Number Contains

The revision is the informative part. Initial 2026 guidance projected about 1 million MA member losses. By the April earnings call that had become 1.3 million, described as a deliberate trade-off for margin recovery and product stability. Either the repricing was more aggressive than modelled, or member sensitivity to benefit reduction ran ahead of the retention assumptions in the bid filings.

Scale it against the programme. KFF put total MA enrollment at roughly 35 million in February 2026, 55% of eligible Medicare beneficiaries, so 1.3 million is about 3.7% of national enrollment relocating from one carrier. The nearest precedent is the involuntary plan-exit wave that forced 2.9 million beneficiaries to switch, and that was every carrier combined.

The exits were geographic as well as actuarial. The 190 counties concentrate in rural markets with thinner networks, less predictable utilisation and higher network adequacy compliance cost per member. Florida, Minnesota and Vermont saw the largest withdrawals, with PPO products specifically dropped in Minnesota and Vermont.

Strip the Development Before Reading the Margin

The MCR moved from roughly 90% at segment level in mid-2025 to 83.9% in Q1 2026, against 84.8% a year earlier, on consolidated revenue of $111.7 billion and $9.0 billion of earnings from operations.

Not all of that is repricing. The Q1 10-Q shows approximately $500 million of favourable prior-year reserve development, meaning reserves set during the high-MCR period of 2025 proved conservative against actual paid claims. That release flatters the reported ratio and will not recur at the same size, so the underlying current-period improvement is smaller than the 90 basis point print. Anyone modelling the trajectory has to isolate it before extrapolating.

The levers behind the rest are specific and durable. Supplemental benefit eligibility for Special Needs Plan members now requires qualifying chronic conditions to access healthy food and utility allowances. HMO and POS plans require referrals for specialist visits, which gates access to higher-cost services directly. The "$0 premium, $0 copay for primary care and Tier 1 prescriptions" messaging held while benefit richness fell underneath it.

Where those members went priced the strategy for everyone else. Humana took roughly 1.2 million of them and its Q1 MBR rose 240 basis points to 89.4%, 550 basis points above UnitedHealthcare's. That gap is the cost of absorbing another carrier's repricing runoff, and it is not random: when supplemental benefits are cut and referrals tightened, the members who move first are the ones with the highest care needs and the strongest reason to shop.

Star Ratings compound it. About 20% of Humana's members sit in 4-star or better plans at an average rating of 3.61, below the 4.0 quality bonus threshold, against roughly 78% for UnitedHealthcare and above 81% for CVS/Aetna. The acquired cohort therefore arrives with higher claims and lower bonus revenue attached.

The Risk Score Leaves With the Member

The MCR improvement and the revenue base move in opposite directions, and the second effect is slower to show up.

Members who leave over cut dental, vision, OTC allowance and transportation benefits are the high utilisers, which is why the ratio improves mechanically. They are also the members carrying the highest risk scores under the CMS-HCC model, so their departure removes risk-adjusted revenue at the same time it removes claims. Whether the trade is positive depends on which effect is larger, and only the claims side has shown up in Q1.

Selection runs the other way too. Healthy, cost-conscious members who chose UnitedHealthcare for its benefit package have the same reason to shop and none of the claims cost, and their exit concentrates the remaining pool from the denominator side. That is the spiral health actuaries model in individual market pricing, running here inside one carrier's MA book.

The Special Needs Plan segment is where the revenue exposure concentrates. SNP enrollment reached 8.0 to 8.2 million in February 2026 and drove 83% of total MA growth, and UnitedHealth holds roughly 51% of that market. Tightening SNP supplemental eligibility while repricing the standard book pushes dual-eligible and chronically ill members toward competitors' D-SNP and C-SNP products, and those members carry more risk-adjusted revenue per head than the standard seniors being shed on purpose.

The rate environment gives none of it back. V28 reached full weight in 2026, cutting valid ICD-10 codes from 9,797 to 7,770 for projected risk score compression of 3.12%, while the DOJ's criminal and civil investigations into UnitedHealth's Medicare billing practices sit over the coding assumptions. The 2027 final rule sets an average effective rate change of 2.48%, a sharp deceleration from 2026's 5.06%. Against medical trend in the 7% to 8% range, that gap gets closed by more benefit reduction, more exits, or the margin the repricing just recovered.

Fixed costs set the floor under how far this can run. Provider contracting, compliance, CMS reporting, Star Ratings management and claims technology do not scale down with membership, and a 7 million member book carries close to the compliance burden of an 8.4 million member one across fewer premium dollars. Network leverage behaves the same way, because contracts negotiated partly on volume guarantees weaken as there is less volume to steer.

Further Reading

• UnitedHealth and Elevance Split the Q2 2026 Managed-Care Recovery – The margin recovery continued into Q2, with UNH's ratio falling another 270 basis points while Elevance's rose, a book-mix divergence rather than a shared industry trend.
• UnitedHealth Q1 2026: 83.9% MBR Resets the Medical Trend Debate – A pricing actuary's read on UNH's 180 bps consensus beat, separating MA pricing discipline from Optum value-based care reserve release.
• Medicare Advantage Plan Exits Force 3 Million to Switch in 2026 – JAMA study quantifying 2.9 million forced disenrollments as carrier exits surged tenfold, with risk pool and bid-level modeling implications.
• Medicare Advantage Premiums Fall While Benefits Shrink: KFF Spotlight Exposes the Actuarial Trade-Off – KFF data showing average premiums declining to $14.00 while supplemental benefits erode across OTC, meals, and transportation.
• 21 Health Systems Drop MA Plans, Exposing Network Adequacy Gaps – How provider departures from MA networks cascade through risk pools, utilization models, and 2027 bid construction.
• D-SNP Enrollment Triples as Medicare Advantage Carriers Chase Higher Margins – Analysis of the SNP product pivot driving 83% of MA growth, with UnitedHealth-Humana 54% SNP concentration risk.
• CMS 2027 MA Final Rule: 2.48% Rate Bump After Near-Flat Advance Notice – The 2027 rate environment that tests whether UNH's 2026 margin recovery can survive decelerating CMS payment growth.
• Both Rating Agencies Hold Health Insurers at Negative for 2026 – AM Best and Moody's converge on negative outlooks across MA, Medicaid, commercial, and ACA segments, with multi-cycle recovery timeline implications.